EFMC-ACSMEDI MedChem Frontiers 2019
Joint Symposium on Medicinal Chemistry Frontiers
Krakow, Poland - June 10-13, 2019
The EFMC - ACSMEDI Medicinal Chemistry Frontiers is co-organised on a biennial basis, as a collaboration between the ACS (American Chemical Society) and the EFMC (European Federation for Medicinal Chemistry).
Frontiers in Medicinal Chemistry 2019 will be jointly organised by EFMC, ACS and the local Polish organiser: the Polish Society of Medicinal Chemistry.
The 2019 edition of the symposium will take place in Krakow, Poland, from June 10-13, 2019.
This biennial meeting is a key symposium in its field with traditionally around 300 participants, from industry and academia. The EFMC - ACSMEDI Medicinal Chemistry Frontiers Meeting attracts a highly targeted audience composed of experts in drug discovery and development, in particular medicinal and synthetic chemists, together with scientists active in the fields of computer assisted drug design, biology, DMPK, pharmacology, early toxicology, as well as chemical and pharmaceutical development. The scientific programme for this meeting will feature a plenary session, followed by sessions covering the latest advances in medicinal chemistry.
The Conference topics will include:
- Adding AI to the Drug Discovery Tool Box
- Advances in Protein Degradation Technologies
- Chemical Biology Tools & Target Engagement Technologies
- Genomics in Drug Discovery : Roles for Chemistry
- GPCRs : a Discovery Powerhouse
- Matrix Metallo-Proteinases
- Multi-Targeted Drugs
- Opioid, Pain, Endo-Cannabinoid
- Targeted Covalent Inhibitors
Discover who will be chairing the sessions here!